MEDAG and type 2 diabetes mellitus: Our study proposed for the first time that MEDAG is a novel hub candidate in the pathogenesis of T2DM through conducting a series of comprehensive bioinformatics analyses on the expression profile of T2DM pancreas islet tissue.